ArticleScientific reports2026
Magnification-independent breast cancer diagnosis using a GWO-enhanced vision transformer with multi-stage stain normalization.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer diagnosis from histopathological images remains a critical yet challenging task due to staining variability, magnification differences, and complex tissue morphology. This study presents a comprehensive preprocessing, balancing, and classification framework for the BreakHis dataset, integrating advanced stain normalization, magnification-wise augmentation, and an optimized Vision Transformer architecture. A four-stage normalization pipeline comprising CLAHE, histogram matching, Shades-of-Gray correction, and Macenko stain normalization was developed to standardize color distribution and enhance structural clarity across 7909 images. To address severe class imbalance, a targeted magnification-specific augmentation strategy expanded the dataset to 11,848 images with equal benign and malignant representation. A Vision Transformer (ViT) model was designed for each of the four magnifications (40X, 100X, 200X, 400X), and further optimized using the Grey Wolf Optimizer (GWO) to automatically tune hyperparameters such as transformer depth, attention heads, embedding dimensions, dropout, and learning rate. Experimental results demonstrate high and consistent performance across magnifications, with accuracies of 92.1%, 92.9%, 93.5%, and 94.0%, respectively. Cross-validation reveals minimal variance, confirming model robustness and generalization. The proposed GWO-ViT framework establishes a reliable, magnification-invariant, and computationally efficient solution for automated breast cancer histopathology classification, offering strong potential for clinical integration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.